Document Detail

Performing nondiagnostic research biopsies in irradiated tissue: a review of scientific, clinical, and ethical considerations.
MedLine Citation:
PMID:  18711189     Owner:  NLM     Status:  MEDLINE    
PURPOSE: Recent development of drugs that target specific pathways in tumors has increased scientific interest in studying drug effects on tumor tissue. As a result, biopsies have become an important part of many early-phase clinical trials. Performing nondiagnostic tumor biopsies raises technical and ethical concerns mostly related to the use of a potentially harmful procedure with no potential benefit to the patient. This issue is complicated by uncertainty about whether performing biopsies in irradiated fields adds significant risk. This article reviews the clinical, scientific, and ethical considerations involved in performing nondiagnostic tumor biopsies in competent adults for research purposes, with a focus on biopsies performed in the setting of therapeutic irradiation. METHODS: Clinical trials that performed biopsies during or within 4 months of the completion of radiotherapy were identified with a literature review. RESULTS: Twenty-nine studies with 2,160 patients were identified. Sixteen of 29 studies reported adverse events (AEs) but did not report active evaluation for biopsy complications. Ten studies did not mention AEs within the study report. At least three studies actively evaluated patients for biopsy complications. Taking this into consideration, 17 (>1%) of 2,160 patients were reported to have biopsy complications, although reporting of AEs was suboptimal in most studies. CONCLUSION: Limited data suggest that biopsies can be performed in irradiated tissues without clinically significant excess risk. Ongoing and future trials including nondiagnostic research biopsies should record and report AEs related to this procedure to provide additional data on safety and toxicity.
Aaron P Brown; David S Wendler; Kevin A Camphausen; Franklin G Miller; Deborah Citrin
Related Documents :
18980499 - Factors associated with survival of neonatal foals with bacteremia and racing performan...
7996509 - Functional localization in the brain with respect to syntactic processing.
19092339 - Sentinel node tumor burden according to the rotterdam criteria is the most important pr...
12893189 - Laparoscopic detection of sentinel lymph nodes followed by lymph node dissection in pat...
17330229 - Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy ...
9706139 - Improved sentinel lymph node localization in patients with primary melanoma with the us...
8175019 - Neoadjuvant chemotherapy for advanced ovarian cancer.
989809 - Skeletal and soft tissue sarcomas. treatment with adjuvant immunotherapy.
23358439 - Analysis of factors influencing skip lymphatic metastasis in pn(2) non-small cell lung ...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of clinical oncology : official journal of the American Society of Clinical Oncology     Volume:  26     ISSN:  1527-7755     ISO Abbreviation:  J. Clin. Oncol.     Publication Date:  2008 Aug 
Date Detail:
Created Date:  2008-08-19     Completed Date:  2008-09-02     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  8309333     Medline TA:  J Clin Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3987-94     Citation Subset:  IM    
Radiation Oncology Branch, National Cancer Institute, 10 CRC, B2-3500, Bethesda, MD 20892, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biopsy / adverse effects,  ethics*,  methods*
Clinical Trials as Topic / ethics*,  methods*
Neoplasms / pathology*,  radiotherapy*
Radiotherapy / adverse effects
Grant Support
Z01 BC010849-01/BC/NCI NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Randomized phase II trial of a toll-like receptor 9 agonist oligodeoxynucleotide, PF-3512676, in com...
Next Document:  Economic evaluation of sunitinib malate for the first-line treatment of metastatic renal cell carcin...